Related Experiment Video

Updated: Aug 20, 2026

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
07:51

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography

Published on: September 22, 2011

Rho-kinase, a potential therapeutic target for the treatment of hypertension

Yoshitaka Hirooka1, Hiroaki Shimokawa, Akira Takeshita

  • 1Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. hyoshi@cardiol.med.kyushu-u.ac.jp

Drug News & Perspectives
|December 18, 2004
PubMed

Insights

The Rho-kinase pathway is crucial in hypertension, with elevated RhoA expression and activity observed in hypertensive rats. Inhibiting Rho-kinase effectively lowers blood pressure and prevents vascular damage in animal models.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Pharmacology

Background:

  • Hypertension involves increased vascular resistance and remodeling.
  • The Rho/Rho-kinase pathway is critical for smooth muscle function in hypertension.
  • Evidence from animal models highlights the role of Rho-kinase in hypertension pathogenesis.

Purpose of the Study:

  • To investigate the role of the Rho/Rho-kinase pathway in hypertension.
  • To assess the therapeutic potential of Rho-kinase inhibitors for hypertension.

Main Methods:

  • Examined RhoA expression and activity in hypertensive rat models (spontaneously hypertensive rats, N(omega)-nitro-L-arginine methyl ester-induced hypertension).
  • Administered Rho-kinase inhibitors (Y-27632, fasudil) to hypertensive and normotensive rats.
  • Evaluated the impact of inhibitors on blood pressure and vascular lesion formation.

Main Results:

  • Increased RhoA expression and activity were found in the aortas of hypertensive rats, even before hypertension onset.
  • Specific Rho-kinase inhibitors significantly reduced blood pressure in hypertensive rats but not in normotensive controls.
  • Rho-kinase inhibitors demonstrated efficacy in preventing hypertensive vascular lesion development.

Conclusions:

  • The Rho/Rho-kinase pathway plays a significant role in the development and maintenance of hypertension.
  • Rho-kinase inhibitors show promise as a potential therapeutic strategy for managing hypertension and its vascular complications.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...